Summit Tx Capital, L.P. United Therapeutics Corp Transaction History
Summit Tx Capital, L.P.
- $2.32 Trillion
- Q2 2025
A detailed history of Summit Tx Capital, L.P. transactions in United Therapeutics Corp stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 6,692 shares of UTHR stock, worth $3.03 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
6,692Holding current value
$3.03 Million% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding UTHR
# of Institutions
745Shares Held
44.1MCall Options Held
340KPut Options Held
318K-
Black Rock Inc. New York, NY5.47MShares$2.48 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.45MShares$2.02 Billion0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.37MShares$1.07 Billion12.42% of portfolio
-
State Street Corp Boston, MA2.17MShares$982 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.12MShares$960 Million0.86% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $20.6B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...